by Michael Nevradakis, Ph.D., Childrens Health Defense:
A peer-reviewed study published last week in the International Journal of Innovative Research in Medical Science found reports of 5,137 cases of cerebral thromboembolism after COVID-19 shots over 36 months, compared with 52 reported cases following flu vaccines and 282 cases for all vaccines over the past 34 years.
COVID-19 vaccines pose a 112,000% greater risk of brain clots and strokes than flu vaccines and a 20,700% greater risk of those symptoms than all other vaccines combined, according to a peer-reviewed study that calls for a global moratorium on the vaccines.
TRUTH LIVES on at https://sgtreport.tv/
The study, published last week in the International Journal of Innovative Research in Medical Science, found reports of 5,137 cases of cerebral thromboembolism after COVID-19 shots over 36 months. This compares to 52 reported cases following flu vaccination and 282 cases for all vaccines over the past 34 years.
According to the study, this represents an “alarming breach in the safety signal threshold concerning cerebral thrombosis adverse events” following COVID-19 vaccination.
The study’s authors — independent researcher Claire Rogers, obstetrician and gynecologist Dr. James A. Thorp, independent researcher Kirstin Cosgrove and cardiologist Dr. Peter McCullough — used data from the U.S. government’s Vaccine Adverse Event Reporting System (VAERS), for their analysis.
The data also indicated 9,821 reports of atrial fibrillation — an irregular heart rhythm that is “the most common identifiable cause of cerebral arterial thromboembolism” — following COVID-19 vaccination in 41 months, compared to 797 cases reported in 34 years for all other vaccines combined.
Rogers told The Defender the findings confirm anecdotal evidence of an increased incidence of stroke seen during and after the COVID-19 pandemic.
Rogers said:
“Cerebral thrombosis case reports in VAERS substantially increased after the COVID vaccines. Not only have clinicians witnessed this in the hospital setting, but the average citizen has seen increased reports of stroke in celebrities, athletes and young people.”
McCullough told The Defender the study employed a “reasonable vaccine safety research strategy” by comparing “a new vaccine to the routine influenza vaccination as a ‘safe’ standard.” He said the results showed “horrific outcomes” following COVID-19 vaccination.
These outcomes led the study’s authors to call for an immediate global moratorium on the use of COVID-19 vaccines “to mitigate further risk with an absolute contraindication in women of reproductive age.”
“Our study joins the growing chorus of analyses calling for all COVID-19 vaccines to be removed from the market,” McCullough said. The withdrawal “should be the first priority” for the next administration.
Spike protein implicated in increased stroke risk
According to the study, the spike protein found in the SARS-CoV-2 virus and COVID-19 vaccines is likely a significant contributor to brain clots and strokes.
“Early in the COVID pandemic, it became evident that there was a thrombogenic effect of the Sars-CoV-2 virus and it is now believed that the spike proteins [are] one of the major contributors to this thrombogenic effect,” the study said.
According to the study, the original strain of the virus led to “a variety of severe thromboembolic events.” However over time, “natural evolution may have resulted in less virulent strains.”
This original risk was replaced by an increase in the incidence of microclots, “affecting the smaller vessels in the circulatory system.” The study noted that it is “widely understood that cumulative exposure to the spike protein” leads to an increased risk of such clots in patients.
According to Rogers, “One mechanism by which the spike protein is thought to contribute to this pathogenesis is by triggering endothelial dysfunction” — a condition that exists when coronary arteries are constricted even though there isn’t a physical blockage.
The study did not compare the different COVID-19 vaccine types — the Pfizer and Moderna mRNA vaccines, and the Johnson & Johnson (Janssen) and AstraZeneca adenovirus-based vaccines. Rogers noted, though, that the adenovirus vaccines were withdrawn in the U.S. and Europe following reports of blood clots.
Read More @ ChildrensHealthDefense.org
